Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-10-17
2008-08-05
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007910, C435S007920, C436S512000, C436S513000, C436S514000, C436S516000
Reexamination Certificate
active
07407764
ABSTRACT:
This invention provides the first blood test which characterizes asthma severity. More specifically, the present invention provides methods of determining the severity of acute asthma in a patient by determining the levels of C5a or C5a-desArg in the patient's blood, plasma or serum.
REFERENCES:
patent: 5190922 (1993-03-01), Luly et al.
patent: 5663148 (1997-09-01), Or et al.
patent: 5861272 (1999-01-01), Li et al.
Teran et al. (Clinical Experimental Allergy 1997 vol. 27, p. 396-405).
Castro Myrelle B.
Drew Hazel P.
Joks Rauno
Khaneja Nandita Mathur
Cheu Changhwa J
Le Long V.
Scully , Scott, Murphy & Presser, P.C.
The Research Foundation of State University of New York
LandOfFree
Plasma C5A levels as an indicator of asthma severity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Plasma C5A levels as an indicator of asthma severity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plasma C5A levels as an indicator of asthma severity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4016947